Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OCT Study of the MGuard Prime Embolic Protection Stent in Patients With Acute ST-segment Elevation Myocardial Infarction

NCT02222116 is registered in ClinicalTrials.gov with InspireMD as lead sponsor.

NCT NCT02222116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02222116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OCT Study of the MGuard Prime Embolic Protection Stent in Patients With Acute ST-segment Elevation Myocardial Infarction
Lead sponsor
InspireMD
Phase
Phase 4
Overall status
Withdrawn
Start date
October 31, 2015
Completion date
January 31, 2016
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

st segment elevated myocardial infarction